Deadly Infection Surges, Prompts Health Officials to Caution Beachgoers
Beachgoers on the Gulf Coast in the U.S. have been urged to exercise caution in order to limit the risk of contracting a bacterial infection that has surged around the region. The flesh-eating bacteria become especially prevalent during summer in coastal water.
In a press release, health authorities in Louisiana revealed that so far, nine cases of the infection have been confirmed and five of the affected people have lost their lives. The state added that over the past 10 years, about seven cases of Vibrio vulnificus infections were confirmed annually. Given that the summer is still on, confirmed infections could rise even further since the tally so far has exceeded that annual average over the previous decade.
The officials urged people to seek medical attention as soon as a wound exposed to saltwater or brackish water starts swelling, feels warm to the touch, becomes red or looks discolored. Affected people are urged to inform the health care professional they visit about the saltwater or brackish water their wound was exposed to so that time isn’t lost during the diagnosis process.
It should be noted that the Gulf area is especially prone to this infection because the bacterium that causes it thrives in saltwater as well as the brackish water in lagoons and estuaries. Most Vibrio vulnificus infections occur between May and October each year, with the bulk of infections reported in Gulf Coast states.
This area is ideal for the bacteria behind this infection due to the combination of heat and salt within the coastal water. There are several Vibrio bacteria types, and the Vibrio vulnificus variety is the deadliest since it kills 20% of those who get the infection.
Florida usually has the highest caseload of these infections when compared to other Gulf Coast states, and this year is no different. Thus far, 14 confirmed cases have been documented and more could occur since the infection window is still ongoing. Two fatalities have so far been reported in the state. In 2025, Florida documented 33 cases of Vibrio vulnificus, with two patients losing their lives.
Most people acquire the infection when a wound or damaged skin comes into contact with infested brackish water or saltwater. Some individuals get infected after eating undercooked or raw shellfish, particularly oysters.
Researchers say climate change is enabling the germs to thrive and spread further north along the coast due to rising temperatures. Data indicates that the spread northwards is extending by 30 miles each year as revealed in new cases reported north of the last northernmost incident previously recorded.
Experts hope that businesses like Co-Diagnostics Inc. (NASDAQ: CODX) that focus on developing and manufacturing diagnostics come up with products that will make it easier to test for this infection even while a person is at home so that prompt treatment can be started to reduce the number of lives lost due to this infection.
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
Doctors in Spain recently handled a fascinating yet terrifying case of a patient that developed brain cancer-like symptoms and…
While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients…
Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production…
The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage…
As July came to an end, the United States reached an undesirable milestone: exceeding the…
Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…